<?xml version="1.0" encoding="UTF-8"?>
<p id="Par80">The intranasal administration of quaternized CS (2-hydroxy-
 <italic>N</italic>,
 <italic>N</italic>,
 <italic>N</italic>-trimethylpropan-1-ammonium chloride CS/
 <italic>N</italic>,
 <italic>O</italic>-carboxymethyl CS) NPs loaded with the combined attenuated live vaccine against Newcastle disease and infectious bronchitis elicited immune response in chicken and induced higher titers of IgG and IgA antibodies, notably stimulated proliferation of lymphocytes and induced higher levels of interleukine-2, interleukine-4, and interferon-Î³ than the commercially combined attenuated live vaccine did. Induction of humoral, cellular, and mucosal immune responses protecting animals from the infection of highly virulent NDV and avian infectious bronchitis virus suggested that such CS derivative could be used as an efficient adjuvant and delivery carrier in mucosal vaccines (Zhao et al. 
 <xref ref-type="bibr" rid="CR245">2017</xref>). Quaternized CS NPs loaded with the combined attenuated live vaccine against Newcastle disease and infectious bronchitis elicited immune response in chicken after intranasal administration.
</p>
